EXHIBIT 10.1
SERIES B CONVERTIBLE PREFERRED STOCK PURCHASE
AGREEMENT
DATED AS OF JULY 30, 2004
AMONG
XSTREAM BEVERAGE GROUP, INC.
AND
THE PURCHASERS LISTED ON EXHIBIT A
<PAGE>
TABLE OF CONTENTS
<TABLE>
<CAPTION>
PAGE
<S>
<C>
ARTICLE I Purchase and Sale of Preferred
Stock......................................................................1
Section 1.1
Purchase and Sale of Preferred Stock and
Warrants........................................1
Section 1.2 The
Conversion
Shares....................................................................2
Section 1.3
Purchase Price and
Closing...............................................................2
ARTICLE II Representations and
Warranties...........................................................................2
Section 2.1
Representations and Warranties of the
Company............................................2
Section 2.2
Representations and Warranties of the
Purchasers........................................13
ARTICLE III
Covenants..............................................................................................16
Section 3.1
Securities
Compliance...................................................................16
Section 3.2
Registration and
Listing................................................................16
Section 3.3
Inspection
Rights.......................................................................16
Section 3.4
Compliance with
Laws....................................................................16
Section 3.5
Keeping of Records and Books of
Account.................................................16
Section 3.6
Reporting
Requirements..................................................................17
Section 3.7
Amendments..............................................................................17
Section 3.8
Other
Agreements........................................................................17
Section 3.9
Distributions...........................................................................17
Section 3.10 Status of
Dividends.....................................................................17
Section 3.11 Use of
Proceeds.........................................................................18
Section 3.12 Future
Financings; Right of First Offer and
Refusal.....................................18
Section 3.13
Reservation of
Shares...................................................................20
Section 3.14 Transfer
Agent
Instructions.............................................................20
Section 3.15
Disposition of
Assets...................................................................21
Section 3.16 Reporting
Status........................................................................21
Section 3.17 Disclosure
of Transaction
..............................................................21
Section 3.18 Disclosure
of Material
Information......................................................21
Section 3.19 Pledge of
Securities....................................................................21
Section 3.20 Charter
Amendment.......................................................................22
Section 3.21 Warrant
Listing.........................................................................22
ARTICLE IV
Conditions..............................................................................................22
Section 4.1
Conditions Precedent to the Obligation of the Company to Sell
the
Shares..................................................................................22
Section 4.2
Conditions Precedent to the Obligation of the Purchasers to
Purchase
the
Shares..............................................................................23
</TABLE>
i
<PAGE>
<TABLE>
<CAPTION>
<S>
<C>
ARTICLE V Stock Certificate
Legend.................................................................................25
Section 5.1
Legend..................................................................................25
ARTICLE VI
Indemnification.........................................................................................26
Section 6.1
General
Indemnity.......................................................................26
Section 6.2
Indemnification
Procedure...............................................................27
ARTICLE VII
Miscellaneous..........................................................................................28
Section 7.1 Fees
and
Expenses.......................................................................28
Section 7.2
Specific Enforcement, Consent to
Jurisdiction...........................................28
Section 7.3
Entire Agreement;
Amendment.............................................................29
Section 7.4
Notices.................................................................................29
Section 7.5
Waivers.................................................................................30
Section 7.6
Headings................................................................................30
Section 7.7
Successors and
Assigns..................................................................30
Section 7.8 No
Third Party
Beneficiaries............................................................30
Section 7.9
Governing
Law...........................................................................30
Section 7.10
Survival................................................................................30
Section 7.11
Counterparts............................................................................31
Section 7.12
Publicity...............................................................................31
Section 7.13
Severability............................................................................31
Section 7.14 Further
Assurances......................................................................31
</TABLE>
ii
<PAGE>
SERIES B CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT
This SERIES B CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT
(the
"Agreement") is dated as of July 30, 2004
by and among XStream Beverage Group,
Inc., a Nevada corporation (the "Company"),
and each of the Purchasers of shares
of Series B Convertible Preferred Stock of
the Company whose names are set forth
on Exhibit A hereto (individually, a
"Purchaser" and collectively, the
"Purchasers").
The parties hereto agree as follows:
ARTICLE I
PURCHASE AND SALE OF PREFERRED STOCK
Section 1.1 Purchase and Sale of Preferred Stock and Warrants.
(a) Upon the following terms and conditions, the Company shall
issue and sell to the Purchasers and each
of the Purchasers shall purchase from
the Company, the number of shares of the
Company's Series B Convertible
Preferred Stock, par value $.001 per share
(the "Preferred Shares"), at a
purchase price of $50,000 per share, set
forth opposite such Purchaser's name on
Exhibit A hereto. The aggregate purchase
price for the Preferred Shares and the
Warrants shall be up to $4,000,000. The
designation, rights, preferences and
other terms and provisions of the Series B
Convertible Preferred Stock are set
forth in the Certificate of Designation of
the Relative Rights and Preferences
of the Series B Convertible Preferred Stock
attached hereto as Exhibit B (the
"Certificate of Designation"). The Company
and the Purchasers are executing and
delivering this Agreement in accordance
with and in reliance upon the exemption
from securities registration afforded by
Rule 506 of Regulation D ("Regulation
D") as promulgated by the United States
Securities and Exchange Commission (the
"Commission") under the Securities Act of
1933, as amended (the "Securities
Act") or Section 4(2) of the Securities
Act.
(b) Upon the following terms and conditions, each of the
Purchasers shall be issued (i) Series A
Warrants, in substantially the form
attached hereto as Exhibit C (the "Series A
Warrants"), to purchase the number
of shares of the Company's Common Stock,
par value $.001 per share (the "Common
Stock") equal to one hundred percent (100%)
of the number of shares of Common
Stock issuable upon conversion of the
Preferred Shares purchased pursuant to the
terms hereof, such amount to be set forth
opposite such Purchaser's name on
Exhibit A hereto, and (ii) Series B
Warrants, in substantially the form attached
hereto as Exhibit D (the "Series B
Warrants" and together with the Series A
Warrants, the "Warrants"), to purchase the
number of shares of Common Stock
equal to fifty percent (50%) of the number
of shares of Common Stock issuable
upon conversion of the Preferred Shares
purchased pursuant to the terms hereof,
such amount to be set forth opposite such
Purchaser's name on Exhibit A attached
hereto. The Warrants shall have an exercise
price equal to the Warrant Price (as
defined in the respective Warrant) and
shall be exercisable as stated therein.
The Warrants shall expire five (5) years
from the Closing Date, as defined
below.
<PAGE>
Section 1.2 The Conversion Shares. Upon the filing of an
amendment to the Company's Articles (as
defined in Section 2.1(c) hereof) with
the Nevada Secretary of State increasing
the number of authorized shares of
Common Stock of the Company (the "Charter
Amendment"), the Company will
authorize and will reserve and covenants to
continue to reserve, free of
preemptive rights and other similar
contractual rights of stockholders, such
number of shares of Common Stock as shall
from time to time be sufficient to
effect the conversion of all of the
Preferred Shares and exercise of the
Warrants then outstanding. Any shares of
Common Stock issuable upon conversion
of the Preferred Shares are herein referred
to as the "Conversion Shares". Any
shares of Common Stock issuable upon
exercise of the Warrants (and such shares
when issued) are herein referred to as the
"Warrant Shares". The Preferred
Shares, the Conversion Shares and the
Warrant Shares are sometimes collectively
referred to as the "Shares".
Section 1.3 Purchase Price and Closing. The Company agrees to
issue and sell to the Purchasers and, in
consideration of and in express
reliance upon the representations,
warranties, covenants, terms and conditions
of this Agreement, the Purchasers,
severally but not jointly, agree to purchase
that number of the Preferred Shares and
Warrants set forth opposite their
respective names on Exhibit A. The
aggregate purchase price of the Preferred
Shares and Warrants being acquired by each
Purchaser is set forth opposite such
Purchaser's name on Exhibit A (for each
such Purchaser, the "Purchase Price" and
collectively referred to as the "Purchase
Prices"). The closing of the purchase
and sale of the Preferred Shares and
Warrants shall take place at the offices of
Jenkens & Gilchrist Parker Chapin LLP,
The Chrysler Building, 405 Lexington
Avenue, New York, New York 10174 (the
"Closing") at 1:00 p.m. (eastern time)
upon the satisfaction of each of the
conditions set forth in Article IV hereof
(the "Closing Date"). Funding with respect
to the Closing shall take place by
wire transfer of immediately available
funds on or prior to the Closing Date.
ARTICLE II
REPRESENTATIONS AND WARRANTIES
Section 2.1 Representations and Warranties of the Company. The
Company hereby makes the following
representations and warranties to the
Purchasers, except as set forth in the
Company's disclosure schedule delivered
with this Agreement as follows:
(a) Organization, Good Standing and Power. The Company is a
corporation duly incorporated, validly
existing and in good standing under the
laws of the State of Nevada and has the
requisite corporate power to own, lease
and operate its properties and assets and
to conduct its business as it is now
being conducted. The Company does not have
any subsidiaries except as set forth
in the Company's Form 10-KSB for the year
ended December 31, 2003, including the
accompanying financial statements (the
"Form 10-KSB"), or in the Company's Form
10-QSB for the fiscal quarters ended March
31, 2004, September 30, 2003, June
30, 2003 or March 31, 2003 (collectively,
the "Form 10-QSB"), or on Schedule
2.1(a) hereto. The Company and each such
subsidiary is duly qualified as a
foreign corporation to do business and is
in good standing in every jurisdiction
in which the nature of the business
conducted or property owned by it makes such
qualification necessary except for any
jurisdiction(s) (alone or in the
aggregate) in which the failure to be so
qualified will not have a Material
Adverse Effect (as defined in Section
2.1(c) hereof) on the Company's financial
condition.
2
<PAGE>
(b) Authorization; Enforcement. Subject to the approval of
Laurus Master Fund, Ltd. ("Laurus") and the
filing of the Charter Amendment, the
Company has the requisite corporate power
and authority to enter into and
perform this Agreement, the Registration
Rights Agreement attached hereto as
Exhibit E (the "Registration Rights
Agreement"), the Irrevocable Transfer Agent
Instructions (as defined in Section 3.14),
the Certificate of Designation, and
the Warrants (collectively, the
"Transaction Documents") and to issue and sell
the Shares and the Warrants in accordance
with the terms hereof. The execution,
delivery and, subject to the filing of the
Charter Amendment, the performance of
the Transaction Documents by the Company
and the consummation by it of the
transactions contemplated hereby and
thereby have been duly and validly
authorized by all necessary corporate
action, and no further consent or
authorization of the Company or its Board
of Directors or stockholders is
required. This Agreement has been duly
executed and delivered by the Company.
The other Transaction Documents will have
been duly executed and delivered by
the Company at the Closing. Each of the
Transaction Documents constitutes, or
shall constitute when executed and
delivered, a valid and binding obligation of
the Company enforceable against the Company
in accordance with its terms, except
as such enforceability may be limited by
applicable bankruptcy, insolvency,
reorganization, moratorium, liquidation,
conservatorship, receivership or
similar laws relating to, or affecting
generally the enforcement of, creditor's
rights and remedies or by other equitable
principles of general application.
(c) Capitalization. The authorized capital stock of the
Company and the shares thereof currently
issued and outstanding as of July 19,
2004 are set forth on Schedule 2.1(c)
hereto. All of the outstanding shares of
the Company's Common Stock and Series B
Convertible Preferred Stock have been
duly and validly authorized. Except as set
forth in this Agreement and the
Registration Rights Agreement and as set
forth on Schedule 2.1(c) hereto, no
shares of Common Stock are entitled to
preemptive rights or registration rights
and there are no outstanding options,
warrants, scrip, rights to subscribe to,
call or commitments of any character
whatsoever relating to, or securities or
rights convertible into, any shares of
capital stock of the Company.
Furthermore, except as set forth in this
Agreement and the Registration Rights
Agreement or on Schedule 2.1(c), there are
no contracts, commitments,
understandings, or arrangements by which
the Company is or may become bound to
issue additional shares of the capital
stock of the Company or options,
securities or rights convertible into
shares of capital stock of the Company.
Except for customary transfer restrictions
contained in agreements entered into
by the Company in order to sell restricted
securities or as set forth on
Schedule 2.1(c) hereto, the Company is not
a party to any agreement granting
registration or anti-dilution rights to any
person with respect to any of its
equity or debt securities. The Company is
not a party to, and it has no
knowledge of, any agreement restricting the
voting or transfer of any shares of
the capital stock of the Company. Except as
set forth on Schedule 2.1(c) hereto,
the offer and sale of all capital stock,
convertible securities, rights,
warrants, or options of the Company issued
prior to the Closing complied with
all applicable Federal and state securities
laws, and no stockholder has a right
of rescission or claim for damages with
respect thereto which would have a
Material Adverse Effect (as defined below)
on the Company's financial condition
or operating results. The Company has
furnished or made available to the
Purchasers true and correct copies of the
Company's Articles of Incorporation as
in effect on the date hereof (the
"Articles"), and the Company's Bylaws as in
3
<PAGE>
effect on the date hereof (the "Bylaws").
For the purposes of this Agreement,
"Material Adverse Effect" means any
material adverse effect on the business,
operations, properties, prospects, or
financial condition of the Company and its
subsidiaries and/or any condition,
circumstance, or situation that would
prohibit or otherwise materially interfere
with the ability of the Company to
perform any of its obligations under this
Agreement in any material respect.
(d) Issuance of Shares. Subject to the filing of the Charter
Amendment, the Preferred Shares and the
Warrants to be issued at the Closing
have been duly authorized by all necessary
corporate action and the Preferred
Shares, when paid for or issued in
accordance with the terms hereof, shall be
validly issued and outstanding, fully paid
and nonassessable and entitled to the
rights and preferences set forth in the
Certificate of Designation. When the
Conversion Shares and the Warrant Shares
are issued in accordance with the terms
of the Certificate of Designation and the
Warrants, respectively, such shares
will be duly authorized by all necessary
corporate action and validly issued and
outstanding, fully paid and nonassessable,
and the holders shall be entitled to
all rights accorded to a holder of Common
Stock.
(e) No Conflicts. The execution, delivery and, subject to the
filing of the Charter Amendment, the
performance of the Transaction Documents by
the Company, the performance by the Company
of its obligations under the
Certificate of Designation and the
consummation by the Company of the
transactions contemplated herein and
therein do not and will not (i) violate any
provision of the Company's Articles or
Bylaws, (ii) conflict with, or constitute
a default (or an event which with notice or
lapse of time or both would become a
default) under, or give to others any
rights of termination, amendment,
acceleration or cancellation of, any
agreement, mortgage, deed of trust,
indenture, note, bond, license, lease
agreement, instrument or obligation to
which the Company is a party or by which it
or its properties or assets are
bound, (iii) create or impose a lien,
mortgage, security interest, charge or
encumbrance of any nature on any property
of the Company under any agreement or
any commitment to which the Company is a
party or by which the Company is bound
or by which any of its respective
properties or assets are bound, or (iv) result
in a violation of any federal, state, local
or foreign statute, rule,
regulation, order, judgment or decree
(including Federal and state securities
laws and regulations) applicable to the
Company or any of its subsidiaries or by
which any property or asset of the Company
or any of its subsidiaries are bound
or affected, except, in all cases other
than violations pursuant to clauses (i)
and (iv) above, for such conflicts,
defaults, terminations, amendments,
accelerations, cancellations and violations
as would not, individually or in the
aggregate, have a Material Adverse Effect.
The business of the Company and its
subsidiaries is not being conducted in
violation of any laws, ordinances or
regulations of any governmental entity,
except for possible violations which
singularly or in the aggregate do not and
will not have a Material Adverse
Effect. The Company is not required under
Federal, state or local law, rule or
regulation to obtain any consent,
authorization or order of, or make any filing
or registration with, any court or
governmental agency in order for it to
execute, deliver or perform any of its
obligations under the Transaction
Documents, or issue and sell the Preferred
Shares, the Warrants, the Conversion
Shares and the Warrant Shares in accordance
with the terms hereof or thereof
(other than any filings which may be
required to be made by the Company with the
Commission or state securities
administrators subsequent to the Closing, any
4
<PAGE>
registration statement which may be filed
pursuant hereto, and the Certificate
of Designation); provided that, for
purposes of the representation made in this
sentence, the Company is assuming and
relying upon the accuracy of the relevant
representations and agreements of the
Purchasers herein.
(f) Commission Documents, Financial Statements. The Common
Stock is registered pursuant to Section
12(b) or 12(g) of the Securities
Exchange Act of 1934, as amended (the
"Exchange Act"), and, since March 31,
2004, the Company has timely filed all
reports, schedules, forms, statements and
other documents required to be filed by it
with the Commission pursuant to the
reporting requirements of the Exchange Act,
including material filed pursuant to
Section 13(a) or 15(d) of the Exchange Act
(all of the foregoing including
filings incorporated by reference therein
being referred to herein as the
"Commission Documents"). The Company has
delivered or made available to each of
the Purchasers true and complete copies of
the Commission Documents filed with
the Commission since March 31, 2004. The
Company has not provided to the
Purchasers any material non-public
information or other information which,
according to applicable law, rule or
regulation, was required to have been
disclosed publicly by the Company but which
has not been so disclosed, other
than with respect to the transactions
contemplated by this Agreement. At the
times of their respective filings, the Form
10-KSB and the Form 10-QSB complied
in all material respects with the
requirements of the Exchange Act and the rules
and regulations of the Commission
promulgated thereunder and other federal,
state and local laws, rules and regulations
applicable to such documents, and,
as of their respective dates, none of the
Form 10-KSB and the Form 10-QSB
contained any untrue statement of a
material fact or omitted to state a material
fact required to be stated therein or
necessary in order to make the statements
therein, in light of the circumstances
under which they were made, not
misleading. The financial statements of the
Company included in the Commission
Documents comply as to form in all material
respects with applicable accounting
requirements and the published rules and
regulations of the Commission or other
applicable rules and regulations with
respect thereto. Such financial statements
have been prepared in accordance with
United States generally accepted
accounting principles ("GAAP") applied on a
consistent basis during the periods
involved (except (i) as may be otherwise
indicated in such financial statements
or the notes thereto or (ii) in the case of
unaudited interim statements, to the
extent they may not include footnotes or
may be condensed or summary
statements), and fairly present in all
material respects the financial position
of the Company and its subsidiaries as of
the dates thereof and the results of
operations and cash flows for the periods
then ended (subject, in the case of
unaudited statements, to normal year-end
audit adjustments).
(g) Subsidiaries. Schedule 2.1(g) hereto sets forth each
subsidiary of the Company, showing the
jurisdiction of its incorporation or
organization and showing the percentage of
each person's ownership. For the
purposes of this Agreement, "subsidiary"
shall mean any corporation or other
entity of which at least a majority of the
securities or other ownership
interest having ordinary voting power
(absolutely or contingently) for the
election of directors or other persons
performing similar functions are at the
time owned directly or indirectly by the
Company and/or any of its other
subsidiaries. All of the outstanding shares
of capital stock of each subsidiary
have been duly authorized and validly
issued, and are fully paid and
nonassessable. There are no outstanding
preemptive, conversion or other rights,
options, warrants or agreements granted or
issued by or binding upon any
5
<PAGE>
subsidiary for the purchase or acquisition
of any shares of capital stock of any
subsidiary or any other securities
convertible into, exchangeable for or
evidencing the rights to subscribe for any
shares of such capital stock. Neither
the Company nor any subsidiary is subject
to any obligation (contingent or
otherwise) to repurchase or otherwise
acquire or retire any shares of the
capital stock of any subsidiary or any
convertible securities, rights, warrants
or options of the type described in the
preceding sentence. Except as set forth
on Schedule 2.1(g) hereto, neither the
Company nor any subsidiary is party to,
nor has any knowledge of, any agreement
restricting the voting or transfer of
any shares of the capital stock of any
subsidiary.
(h) No Material Adverse Change. Since March 31, 2004, the
Company has not experienced or suffered any
Material Adverse Effect, except as
disclosed on Schedule 2.1(h) hereto.
(i) No Undisclosed Liabilities. Except as set forth on
Schedule 2.1(i) hereto, or in the
Commission Documents, neither the Company nor
any of its subsidiaries has any
liabilities, obligations, claims or losses
(whether liquidated or unliquidated,
secured or unsecured, absolute, accrued,
contingent or otherwise) other than those
incurred in the ordinary course of the
Company's or its subsidiaries respective
businesses since March 31, 2004 and
which, individually or in the aggregate, do
not or would not have a Material
Adverse Effect on the Company or its
subsidiaries.
(j) No Undisclosed Events or Circumstances. Except as set
forth on Schedule 2.1(j) hereto, no event
or circumstance has occurred or exists
with respect to the Company or its
subsidiaries or their respective businesses,
properties, prospects, operations or
financial condition, which, under
applicable law, rule or regulation,
requires public disclosure or announcement
by the Company but which has not been so
publicly announced or disclosed.
(k) Indebtedness. The Form 10-KSB, Form 10-QSB or Schedule
2.1(k) hereto sets forth as of a recent
date all outstanding secured and
unsecured Indebtedness of the Company or
any subsidiary, or for which the
Company or any subsidiary has commitments.
For the purposes of this Agreement,
"Indebtedness" shall mean (a) any
liabilities for borrowed money or amounts owed
in excess of $100,000 (other than trade
accounts payable incurred in the
ordinary course of business), (b) all
guaranties, endorsements and other
contingent obligations in respect of
Indebtedness of others, whether or not the
same are or should be reflected in the
Company's balance sheet (or the notes
thereto), except guaranties by endorsement
of negotiable instruments for deposit
or collection or similar transactions in
the ordinary course of business; and
(c) the present value of any lease payments
in excess of $25,000 due under
leases required to be capitalized in
accordance with GAAP. Except as set forth
on Schedule 2.1(k), neither the Company nor
any subsidiary is in default with
respect to any Indebtedness.
(l) Title to Assets. Except as disclosed on Schedule 2.1(l)
hereto, each of the Company and the
subsidiaries has good and marketable title
to all of its real and personal property
reflected in the Form 10-KSB, free and
clear of any mortgages, pledges, charges,
liens, security interests or other
encumbrances, except for those indicated in
the Form 10-KSB, Form 10-QSB or on
Schedule 2.1(l) hereto or such that,
individually or in the aggregate, do not
cause a Material Adverse Effect on the
Company's financial condition or
operating results. All said leases of the
Company and each of its subsidiaries
are valid and subsisting and in full force
and effect.
6
<PAGE>
(m) Actions Pending. There is no action, suit, claim,
investigation, arbitration, alternate
dispute resolution proceeding or any other
proceeding pending or, to the knowledge of
the Company, threatened against the
Company or any subsidiary which questions
the validity of this Agreement or any
of the other Transaction Documents or the
transactions contemplated hereby or
thereby or any action taken or to be taken
pursuant hereto or thereto. Except as
set forth in the Form 10-KSB, Form 10-QSB
or on Schedule 2.1(m) hereto, there is
no action, suit, claim, investigation,
arbitration, alternate dispute resolution
proceeding or any other proceeding pending
or, to the knowledge of the Company,
threatened, against or involving the
Company, any subsidiary or any of their
respective properties or assets. Except as
set forth in the Form 10-KSB, Form
10-QSB or Schedule 2.1(m) hereto, there are
no outstanding orders, judgments,
injunctions, awards or decrees of any
court, arbitrator or governmental or
regulatory body against the Company or any
subsidiary or any officers or
directors of the Company or subsidiary in
their capacities as such.
(n) Compliance with Law. The business of the Company and the
subsidiaries has been and is presently
being conducted in accordance with all
applicable federal, state and local
governmental laws, rules, regulations and
ordinances, except as set forth in the Form
10-KSB, Form 10-QSB, or such that,
individually or in the aggregate, do not
cause a Material Adverse Effect. The
Company and each of its subsidiaries have
all franchises, permits, licenses,
consents and other governmental or
regulatory authorizations and approvals
necessary for the conduct of its business
as now being conducted by it unless
the failure to possess such franchises,
permits, licenses, consents and other
governmental or regulatory authorizations
and approvals, individually or in the
aggregate, could not reasonably be expected
to have a Material Adverse Effect.
(o) Taxes. The Company and each of the subsidiaries has
accurately prepared and filed all federal,
state and other tax returns required
by law to be filed by it, has paid or made
provisions for the payment of all
taxes shown to be due and all additional
assessments, and adequate provisions
have been and are reflected in the
financial statements of the Company and the
subsidiaries for all current taxes and
other charges to which the Company or any
subsidiary is subject and which are not
currently due and payable. None of the
federal income tax returns of the Company
or any subsidiary have been audited by
the Internal Revenue Service. The Company
has no knowledge of any additional
assessments, adjustments or contingent tax
liability (whether federal or state)
of any nature whatsoever, whether pending
or threatened against the Company or
any subsidiary for any period, nor of any
basis for any such assessment,
adjustment or contingency.
(p) Certain Fees. Except as set forth in this Agreement or on
Schedule 2.1(p) hereto, no brokers, finders
or financial advisory fees or
commissions will be payable by the Company
or any subsidiary or any Purchaser
with respect to the transactions
contemplated by this Agreement.
(q) Disclosure. To the best of the Company's knowledge,
neither this Agreement or the Schedules
hereto nor any other documents,
certificates or instruments furnished to
the Purchasers by or on behalf of the
Company or any subsidiary in connection
with the transactions contemplated by
7
<PAGE>
this Agreement contain any untrue statement
of a material fact or omit to state
a material fact necessary in order to make
the statements made herein or
therein, in the light of the circumstances
under which they were made herein or
therein, not misleading.
(r) Operation of Business. The Company and each of the
subsidiaries owns or possesses, subject to
the intellectual property pledge
rights granted to Laurus in certain
agreements entered into between the Company
and Laurus on May 14, 2004, all patents,
trademarks, domain names (whether or
not registered) and any patentable
improvements or copyrightable derivative
works thereof, websites and intellectual
property rights relating thereto,
service marks, trade names, copyrights,
licenses and authorizations as set forth
in the Form 10-KSB, Form 10-QSB and on
Schedule 2.1(r) hereto, and all rights
with respect to the foregoing, which are
necessary for the conduct of its
business as now conducted without any
conflict with the rights of others.
(s) Environmental Compliance. The Company and each of its
subsidiaries have obtained all material
approvals, authorization, certificates,
consents, licenses, orders and permits or
other similar authorizations of all
governmental authorities, or from any other
person, that are required under any
Environmental Laws. The Form 10-KSB or Form
10-QSB describes all material
permits, licenses and other authorizations
issued under any Environmental Laws
to the Company or its subsidiaries.
"Environmental Laws" shall mean all
applicable laws relating to the protection
of the environment including, without
limitation, all requirements pertaining to
reporting, licensing, permitting,
controlling, investigating or remediating
emissions, discharges, releases or
threatened releases of hazardous
substances, chemical substances, pollutants,
contaminants or toxic substances, materials
or wastes, whether solid, liquid or
gaseous in nature, into the air, surface
water, groundwater or land, or relating
to the manufacture, processing,
distribution, use, treatment, storage, disposal,
transport or handling of hazardous
substances, chemical substances, pollutants,
contaminants or toxic substances, material
or wastes, whether solid, liquid or
gaseous in nature. The Company has all
necessary governmental approvals required
under all Environmental Laws and used in
its business or in the business of any
of its subsidiaries. The Company and each
of its subsidiaries are also in
compliance with all other limitations,
restrictions, conditions, standards,
requirements, schedules and timetables
required or imposed under all
Environmental Laws. Except for such
instances as would not individually or in
the aggregate have a Material Adverse
Effect, there are no past or present
events, conditions, circumstances,
incidents, actions or omissions relating to
or in any way affecting the Company or its
subsidiaries that violate or may
violate any Environmental Law after the
Closing Date or that may give rise to
any environmental liability, or otherwise
form the basis of any claim, action,
demand, suit, proceeding, hearing, study or
investigation (i) under any
Environmental Law, or (ii) based on or
related to the manufacture, processing,
distribution, use, treatment, storage
(including without limitation underground
storage tanks), disposal, transport or
handling, or the emission, discharge,
release or threatened release of any
hazardous substance.
(t) Books and Record Internal Accounting Controls. The books
and records of the Company and its
subsidiaries accurately reflect in all
material respects the information relating
to the business of the Company and
the subsidiaries, the location and
collection of their assets, and the nature of
all transactions giving rise to the
obligations or accounts receivable of the
8
<PAGE>
Company or any subsidiary. The Company and
each of its subsidiaries maintain a
system of internal accounting controls
sufficient, in the judgment of the
Company, to provide reasonable assurance
that (i) transactions are executed in
accordance with management's general or
specific authorizations, (ii)
transactions are recorded as necessary to
permit preparation of financial
statements in conformity with GAAP and to
maintain asset accountability, (iii)
access to assets is permitted only in
accordance with management's general or
specific authorization and (iv) the
recorded accountability for assets is
compared with the existing assets at
reasonable intervals and appropriate
actions is taken with respect to any
differences.
(u) Material Agreements. Except as set forth in the Form
10-KSB, Form 10-QSB or on Schedule 2.1(u)
hereto, neither the Company nor any
subsidiary is a party to any written or
oral contract, instrument, agreement,
commitment, obligation, plan or
arrangement, a copy of which would be required
to be filed with the Commission as an
exhibit to a registration statement on
Form S-3 or applicable form (collectively,
"Material Agreements") if the Company
or any subsidiary were registering
securities under the Securities Act. Except
as set forth on Schedule 2.1(u) or in the
Commission Documents, the Company and
each of its subsidiaries has in all
material respects performed all the
obligations required to be performed by
them to date under the foregoing
agreements, have received no notice of
default and, to the best of the Company's
knowledge are not in default under any
Material Agreement now in effect, the
result of which could cause a Material
Adverse Effect. Except as set forth on
Schedule 2.1(u) or in the Commission
Documents, no written or oral contract,
instrument, agreement, commitment,
obligation, plan or arrangement of the
Company or of any subsidiary limits or
shall limit the payment of dividends on
the Company's Preferred Shares, other
Preferred Stock, if any, or its Common
Stock. (v) Transactions with Affiliates.
Except as set forth in the Form 10-KSB,
Form 10-QSB or on Schedule 2.1
(v) hereto, there are no loans, leases, agreements, contracts,
royalty agreements, management contracts or
arrangements or other continuing
transactions between (a) the Company, any
subsidiary or any of their respective
customers or suppliers on the one hand, and
(b) on the other hand, any officer,
employee, consultant or director of the
Company, or any of its subsidiaries, or
any person owning any capital stock of the
Company or any subsidiary or any
member of the immediate family of such
officer, employee, consultant, director
or stockholder or any corporation or other
entity controlled by such officer,
employee, consultant, director or
stockholder, or a member of the immediate
family of such officer, employee,
consultant, director or stockholder.
(w) Securities Act of 1933. Based in material part upon the
representations herein of the Purchasers,
the Company has complied and will
comply with all applicable federal and
state securities laws in connection with
the offer, issuance and sale of the Shares
and the Warrants hereunder. Neither
the Company nor anyone acting on its
behalf, directly or indirectly, has or will
sell, offer to sell or solicit offers to
buy any of the Shares, the Warrants or
similar securities to, or solicit offers
with respect thereto from, or enter
into any preliminary conversations or
negotiations relating thereto with, any
person, or has taken or will take any
action so as to bring the issuance and
sale of any of the Shares and the Warrants
under the registration provisions of
the Securities Act and applicable state
securities laws, and neither the Company
nor any of its affiliates, nor any person
acting on its or their behalf, has
engaged in any form of general solicitation
or general advertising (within the
meaning of Regulation D under the
Securities Act) in connection with the offer
or sale of any of the Shares and the
Warrants.
9
<PAGE>
(x) Governmental Approvals. Except as set forth in the Form
10-KSB or Form 10-QSB, and except for the
filing of any notice prior or
subsequent to the Closing Date that may be
required under applicable state
and/or Federal securities laws (which if
required, shall be filed on a timely
basis), including the filing of a Form D
and a registration statement or
statements pursuant to the Registration
Rights Agreement, and the filing of the
Certificate of Designation with the
Secretary of State for the State of Nevada,
no authorization, consent, approval,
license, exemption of, filing or
registration with any court or governmental
department, commission, board,
bureau, agency or instrumentality, domestic
or foreign, is or will be necessary
for, or in connection with, the execution
or delivery of the Preferred Shares
and the Warrants, or for the performance by
the Company of its obligations under
the Transaction Documents.
(y) Employees. Neither the Company nor any subsidiary has any
collective bargaining arrangements or
agreements covering any of its employees,
except as set forth in the Form 10-KSB,
Form 10-QSB or on Schedule 2.1(y)
hereto. Except as set forth in the Form
10-KSB, Form 10-QSB or on Schedule
2.1(y) hereto, neither the Company nor any
subsidiary has any employment
contract, agreement regarding proprietary
information, non-competition
agreement, non-solicitation agreement,
confidentiality agreement, or any other
similar contract or restrictive covenant,
relating to the right of any officer,
employee or consultant to be employed or
engaged by the Company or such
subsidiary. Since September 30, 2003, no
officer, consultant or key employee of
the Company or any subsidiary whose
termination, either individually or in the
aggregate, could have a Material Adverse
Effect, has terminated or, to the
knowledge of the Company, has any present
intention of terminating his or her
employment or engagement with the Company
or any subsidiary.
(z) Absence of Certain Developments. Except as provided on
Schedule 2.1(z) hereto, since March 31,
2004, neither the Company nor any
subsidiary has:
(i) issued any stock, bonds or other corporate securities or
any right, options or warrants with respect
thereto;
(ii) borrowed any amount in excess of $300,000 or incurred
or become subject to any other liabilities
in excess of $100,000 (absolute or
contingent) except current liabilities
incurred in the ordinary course of
business which are comparable in nature and
amount to the current liabilities
incurred in the ordinary course of business
during the comparable portion of its
prior fiscal year, as adjusted to reflect
the current nature and volume of the
business of the Company and its
Subsidiaries;
(iii) discharged or satisfied any lien or encumbrance in
excess of $250,000 or paid any obligation
or liability (absolute or contingent)
in excess of $250,000, other than current
liabilities paid in the ordinary
course of business;
10
<PAGE>
(iv) declared or made any payment or distribution of cash or
other property to stockholders with respect
to its stock, or purchased or
redeemed, or made any agreements so to
purchase or redeem, any shares of its
capital stock, in each case in excess of
$50,000 individually or $100,000 in the
aggregate;
(v) sold, assigned or transferred any other tangible assets,
or canceled any debts or claims, in each
case in excess of $250,000, except in
the ordinary course of business;
(vi) sold, assigned or transferred any patent rights,
trademarks, trade names, copyrights, trade
secrets or other intangible assets or
intellectual property rights in excess of
$250,000, or disclosed any proprietary
confidential information to any person
except to customers in the ordinary
course of business or to the Purchasers or
their representatives;
(vii) suffered any material losses or waived any rights of
material value, whether or not in the
ordinary course of business, or suffered
the loss of any material amount of
prospective business;
(viii) made any changes in employee compensation except in
the ordinary course of business and
consistent with past practices;
(ix) made capital expenditures or commitments therefor that
aggregate in excess of $100,000;
(x) entered into any material transaction, whether or not in
the ordinary course of business;
(xi) made charitable contributions or pledges in excess of
$25,000;
(xii) suffered any material damage, destruction or casualty
loss, whether or not covered by
insurance;
(xiii) experienced any material problems with labor or
management in connection with the terms and
conditions of their employment; or
(xiv) entered into an agreement, written or otherwise, to
take any of the foregoing actions.
(aa) Public Utility Holding Company Act and Investment Company
Act Status. The Company is not a "holding
company" or a "public utility company"
as such terms are defined in the Public
Utility Holding Company Act of 1935, as
amended. The Company is not, and as a
result of and immediately upon the Closing
will not be, an "investment company" or a
company "controlled" by an "